These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2275892)

  • 1. Mechanism of action of sotalol in supraventricular arrhythmias.
    Brugada P; Smeets JL; Brugada J; Farré J
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():619-23. PubMed ID: 2275892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M; Breithardt G
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
    Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.
    Daubert C; Mabo P; Gras D; Leclercq C
    Eur Heart J; 1993 Nov; 14 Suppl H():67-73. PubMed ID: 7904939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic properties of sotalol and d-sotalol. A current view.
    Touboul P
    Eur Heart J; 1993 Nov; 14 Suppl H():24-9. PubMed ID: 7904935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
    Honerjäger P; Schmidt G
    Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol.
    Waleffe A; Nzayinambaho K; Rodriguez LM; Dehareng A; Kulbertus HE
    Eur Heart J; 1989 Dec; 10(12):1084-9. PubMed ID: 2606117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sotalol in patients with Wolff-Parkinson-White syndrome.
    Kunze KP; Schlüter M; Kuck KH
    Circulation; 1987 May; 75(5):1050-7. PubMed ID: 3568305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute prolongation of myocardial refractoriness by sotalol.
    Bennett DH
    Br Heart J; 1982 Jun; 47(6):521-6. PubMed ID: 7082500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population.
    Chandler SF; Chu E; Whitehill RD; Bevilacqua LM; Bezzerides VJ; DeWitt ES; Alexander ME; Abrams DJ; Triedman JK; Walsh EP; Mah DY
    Heart Rhythm; 2020 Jun; 17(6):984-990. PubMed ID: 32014568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sotalol: a novel beta-blocker with class III anti-arrhythmic activity.
    Leibowitz D
    J Clin Pharmacol; 1993 Jun; 33(6):508-12. PubMed ID: 8366175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S; Ricard P
    Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol.
    Madrid AH; Moro C; Maŕin Huerta EM; Novo L; Mestre JL
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2111-5. PubMed ID: 1279609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of sotalol--just another beta blocker?
    Nathan AW; Hellestrand KJ; Bexton RS; Ward DE; Spurrell RA; Camm AJ
    Br Heart J; 1982 Jun; 47(6):515-20. PubMed ID: 7082499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation.
    Aliot E; Sadoul N; De Chillou C
    Eur Heart J; 1993 Nov; 14 Suppl H():74-7. PubMed ID: 7904940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intravenous sotalol for suppressing inducibility of supraventricular tachycardias at rest and during isometric exercise.
    Huikuri HV; Koistinen MJ; Takkunen JT
    Am J Cardiol; 1992 Feb; 69(5):498-502. PubMed ID: 1736614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
    Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.